Pharmacy chain Rite Aid files for bankruptcy amid declining sales and opioid lawsuits

Major U.S. pharmacy chain Rite Aid has filed for bankruptcy, obtained fresh funding, and initiated restructuring while dealing with declining sales and opioid-related lawsuits.

The bankruptcy filing: Rite Aid declared bankruptcy and secured $3.45 billion in new funding as part of a restructuring plan on Sunday.
* In 2022, Rite Aid agreed to a settlement up to $30 million to resolve lawsuits alleging pharmacies contributed to an oversupply of prescription opioids.
* The company said the bankruptcy filing was part of the process to reduce debt and resolve litigation claims equitably.

The leadership transition: The pharmacy chain has appointed Jeffrey Stein as its CEO, replacing interim CEO Elizabeth Burr, who remains on the board.
* Stein, who heads a financial advisory firm, took over on Sunday.

Noncompliance with listing standards: Rite Aid notified the New York Stock Exchange earlier this month that it wasn’t in compliance with listing standards, but its stock continues to trade during a grace period.
* The bankruptcy filing and violation of listing standards won’t affect its business operations or its reporting requirements to the U.S. Securities and Exchange Commission.

Store closures and financial challenges: Rite Aid plans to close some underperforming stores among its more than 2,100 pharmacies located in 17 states.
* It reported its revenue fell to $5.7 billion in the fiscal quarter ending June 3, down from $6.0 billion a year earlier, with a net loss of $306.7 million.

View original article here

This summary was created by an AI system. The use of this summary is subject to our Terms of Service.

Contact us about this post

Posted

in

by

Tags:

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *